Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant TNFRSF8 antibody

TNFRSF8 Reactivity: Human FACS, IHC, IF, ELISA, Act Host: Rabbit Chimeric Ki-3 unconjugated Recombinant Antibody
Catalog No. ABIN7072328
  • Target See all TNFRSF8 Antibodies
    TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))
    Antibody Type
    Recombinant Antibody
    Reactivity
    • 148
    • 32
    • 19
    • 16
    Human
    Host
    • 91
    • 71
    • 14
    • 4
    • 1
    • 1
    • 1
    Rabbit
    Clonality
    • 111
    • 71
    • 1
    Chimeric
    Conjugate
    • 80
    • 15
    • 13
    • 12
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This TNFRSF8 antibody is un-conjugated
    Application
    • 118
    • 56
    • 52
    • 46
    • 36
    • 27
    • 27
    • 26
    • 13
    • 7
    • 6
    • 6
    • 6
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Flow Cytometry (FACS), Immunohistochemistry (IHC), Immunofluorescence (IF), ELISA, Activation (Act)
    Purpose
    Anti-CD30 [Ki-3], Rabbit IgG, kappa
    Specificity
    The antibody binds to CD30.
    Characteristics

    Original Species of Ab: Mouse

    Original Format of Ab: IgG2b

    Purification
    Protein A affinity purified
    Immunogen
    Human CD30.
    Clone
    Ki-3
    Isotype
    IgG kappa
    Top Product
    Discover our top product TNFRSF8 Primary Antibody
  • Application Notes
    The antibody binds specifically to CD30, a cell membrane protein which belongs to the tumour necrosis factor receptor family. Incubation of CD30 positive L540 cells with Ki-3 antibody weakly enhances release of soluble CD30 (in contrast to Ki-4, Ab00475). CD30 is expressed on activated lymphocytes, and binding by its ligands TRAF2 and TRAF5 results in the activation of NF-kappaB, thereby regulating gene expression. CD30 is also associated with Hodgkin Lymphoma, and its expression acts as a tumour marker. Targeting the CD30 antigen with specific monoclonal antibodies is a possible therapy for Hodgkin's lymphoma.
    Comment

    This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques.

    Restrictions
    For Research Use only
  • Concentration
    1 mg/mL
    Buffer
    PBS with 0.02 % Proclin 300.
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-20 °C
    Storage Comment
    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Target
    TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))
    Alternative Name
    CD30 (TNFRSF8 Products)
    Background
    TNFRSF8, Tumor necrosis factor receptor superfamily member 8, CD30L receptor, Ki-1 antigen, Lymphocyte activation antigen CD30
    UniProt
    P28908
You are here:
Support